Objectives: To investigate the association of sleep characteristics with prevalent hypertension, diabetes, and obesity in a multiethnic cohort. Design: This study used a population-based cross-sectional study design. Setting: Participants were recruited between 2009 and 2011 from Chicago, Illinois, and the surrounding suburbs. Participants: Participants were 492 adults aged 35 to 64 years who self-reported as white, black, Hispanic, or Asian and who had a low likelihood of sleep apnea based on the apnea screening questionnaires and 1 night of apnea screening using an in-home device (apnea hypopnea index b15 or oxygen desaturation index b10). Measurements: Participants wore a wrist actigraphy monitor (Actiwatch™) for 7 days. During a clinical examination, participants completed questionnaires about sleep, other health behaviors, and medical history and had their blood pressure, anthropometric measures, and fasting blood glucose measured; metabolic risk factors were determined based on standard clinical guidelines. Results: The prevalence of hypertension, obesity, and diabetes was 17.1%, 5.5%, and 35.4%, respectively. Sleep duration was not associated with any cardiovascular risk factor. There was a significantly increased odds for hypertension (odds ratio [OR], 1.05; 95% confidence interval [CI], 1.01-1.08) and obesity (OR, 1.03; 95% CI, 1.00-1.05) associated with higher sleep fragmentation (per 1%). There was also a significantly increased odds for hypertension associated with poorer self-reported sleep quality (OR, 1.14 [95% CI, 1.05-1.24] per 1-unit higher Pittsburgh Sleep Quality Index global score). Conclusion: Objective and self-reported sleep quality may be more important than duration in relation to prevalent hypertension.
health. 6 Consequently, sleep quality may provide additional insights beyond sleep duration. To our knowledge, no prior studies have investigated a combination of objectively determined sleep characteristics and self-reported quality measures. Prior studies by our research group 7, 8 and others 4,9-13 describe differences in sleep characteristics by race/ethnicity. These differences may be particularly relevant given the higher prevalence of cardiovascular (eg, hypertension) and metabolic (eg, obesity, diabetes) risk factors in blacks, Hispanics, and some Asians (particularly for diabetes). [14] [15] [16] [17] Recent reviews highlight the contribution of sleep to cardiovascular disease risk factors and highlight the potential for differences in sleep to contribute to disparities. 18 Consequently, more research is needed in multiracial/ethnic samples using both selfreported and objective assessment of sleep alongside measurements (vs self-report) of cardiovascular disease risk factors. Prior literature has not screened for sleep apnea or taken into risk for sleep apnea using objective screening tools. Sleep apnea is estimated to affect 10% to 20% of the population and rates have gone up over time. 19 Sleep apnea is inversely associated with sleep duration and quality. Hypoxia is independently associated with endothelial dysfunction, which underlies cardiometabolic disorders. 20, 21 Because sleep interruption occurs during the sleep period, selfreported sleep is plagued by misreporting in persons with apnea. Although the use of objective measures of sleep can overcome this limitation, characterization of breathing, chest movements, and oxygen saturation overnight is required, at a minimum, to capture apnea risk. No prior population-based studies have captured this information alongside objectively measured sleep, although apnea could confound the association of sleep with cardiometabolic disorders. Characterization of apnea risk is required to test the association of short sleep independent of apnea on cardiometabolic risk. Our first objective was to expand beyond the current literature to determine whether objectively determined sleep duration and sleep quality are associated with cardiometabolic disorders (ie, diabetes, hypertension, and obesity) in adults who have a low likelihood of having sleep apnea. Because prior reports have suggested that there is a U-shaped association with too much or too little sleep resulting in an increased odds of negative health outcomes, we hypothesized that sleep duration would display a U-shaped association with cardiometabolic risk factors and that sleep quality would be inversely associated with prevalence. We evaluated whether any observed associations remained after adjustment for demographic characteristics, health behaviors, and other clinical characteristics. Our second objective was to use this multiracial/ethnic sample that includes white, black, Hispanic, and Asian adults in roughly equal numbers to explore whether the relationship between sleep and cardiometabolic risk factors is moderated by race (ie, effect measure modification). Furthermore, given differences in sleep by sex, 22 we also tested effect modification by sex.
Methods

Participants
The Chicago Area Sleep Study was a cross-sectional study conducted between 2009 and 2011. 23 Approximately 650 participants aged 35 to 64 years from Chicago, Illinois, and the surrounding suburbs were recruited from neighborhoods with heavy concentrations of adults from the racial and ethnic groups of interest (ie, white, black, Hispanic, and Asian) using commercial telephone lists from Info USA. Hispanics were defined as any individual claiming Hispanic ethnicity; they were not included in the white, black, or Asian category to ensure that the groups were mutually exclusive. We attempted to restrict our recruitment of Asians to those of East Asian descent based on self-report (eg, Chinese, Korean, Japanese, and Vietnamese), given the variation in cardiometabolic risk profiles among individuals from across the Asian continent. 24 For example, rates of diabetes are lower among East Asians than Southeast Asians (eg, Filipinos). 16 Further details on the methods of recruitment are published elsewhere. 23 
Study design
Individuals who met the inclusion criteria of having a body mass index (BMI) b35 kg/m 2 and a low likelihood of sleep apnea as determined by the Berlin questionnaire and the Snoring, Tiredness, Observed apnea, blood Pressure, Body mass index, Age, Neck circumference and Gender (STOP-BANG) questionnaire were invited to attend a clinical examination. 25, 26 At the initial examination, participants were consented and given all questionnaires and sleep equipment. They were instructed to wear the sleep watch for 7 days and the apnea screening device for 1 night and to return to the clinic for a second examination within 8 to 14 days when all cardiovascular risk factors were measured. The study protocol was approved by the institutional review board at Northwestern University. Informed consent was obtained for all participants involved.
Sleep characteristics
Participants wore an actigraphy device (the Actiwatch™ 2; Phillips Respironics, Bend, OR) on their wrist for 1 week. The actigraphy device contains a piezoelectric accelerometer that captures movement in orthogonal dimensions. These movements were collected in 30-second epochs and plotted as a histogram, and the device software was used an algorithm to determine sleep duration based on the absence of movement during time in bed. The device also contains a marker, which participants were asked to press any time they went to bed or woke up. In addition, participants recorded bed times, wake times, and any nap times in a Karolinska sleep dairy. A member of the research team identified sleep intervals using the sleep logs and event markers. To ensure quality control, a 10% random sample of sleep records was re-read by a second member of the research team. Sleep duration was based on the total amount of sleep obtained during their primary sleep period (which was nocturnal for most participants). The bed time and wake time for this primary sleep period were identified based on the sleep logs and event markers. We then averaged across all available days of rerecording, which was 7 days for most subjects and therefore no weighting by day of the week was required. Sleep fragmentation is a measure of restlessness during sleep that sums the percentage of sleep spent moving (more than 2 activity counts in a 1-minute period) and the percentage of consecutive phases of no movement that are less than 1 minute in duration determined using the actigraph. Higher values indicate sleep that is more fragmented. The total scores for the Pittsburgh Sleep Quality Index (PSQI; score range, 5-18) and Epworth Sleepiness Scale (ESS; score range, 6-22) were used to measure perceived global sleep quality and daytime sleepiness, respectively, and both have been validated for that purpose. 27, 28 There were more final scores missing for the PSQI survey than for the other measures (n = 153) because it is required that the first 9 questions be answered-a single missing question in this section prevents the whole survey from being scored. 28 
Cardiometabolic factors
The cardiometabolic risk factors of interest were hypertension, obesity, and diabetes. Participants were asked to fast for a minimum of 12 hours before their examination and to bring all of their prescription and over-the-counter medications with them to the examination. Measurements were collected between 7:30 AM and 11:00 AM.
Blood pressure was measured at the clinical examination with an automated cuff after 5 minutes of rest; 3 measurements were collected and the final 2 were averaged. Hypertension was determined if any of the following criteria were met: systolic blood pressure ≥140 mm Hg, a diastolic blood pressure ≥90 mm Hg, or a self-reported use of antihypertensive medications. Height and weight were measured using a stadiometer and balance scale, respectively; BMI was determined as weight (kg)/height (meters) 2 . Obesity was defined as a BMI ≥30 kg/m 2 for non-Asians and a BMI ≥27.5 kg/m 2 for Asians. 29 Blood was drawn into citrate vacutainer tubes while participants were seated. The tubes were centrifuged at 3000 rpm at 4°C for 20 minutes and then stored at −70°C. Fasting glucose levels were determined by plasma spectrophotometry and hemoglobin A1c levels were determined from whole blood immunoturbidimetric assay. Diabetes was determined if participants had any of the following: fasting glucose ≥126 mg/dL, a hemoglobin A1c ≥6.5%, or a selfreported use of diabetes control medications. 30 All 3 factors were treated as dichotomous variables.
Other covariates
Self-reported questionnaires were used to measure demographic and lifestyle behaviors. Demographic characteristics assessed were age, race, sex, socioeconomic status (as determined by education in years), and work status (unemployed/retired, day shift, or night shift). The lifestyle covariates were smoking status and alcohol consumption status. Smoking and alcohol consumption were categorized into current, former, or never. Waist circumference was measured in duplicate from participants standing up right at the visual midway point between xiphoid process of the sternum and umbilicus. Measurements were captured to the nearest 0.5 cm and averaged. Depressive symptoms were assessed using the Centers for Epidemiologic Studies-Depression scale; a score greater than or equal to 16 is associated with major depressive disorder. 31, 32 To restrict the sample to participants with a low likelihood of sleep apnea, at the first visit, participants were asked to wear the ApneaLinkPlus apnea-screening device, using a combination of devices including the nasal cannula, a chest belt to detect respiratory effort, and a pulse oximeter to measure oxygen saturation, for 1 night. Post hoc exclusions for analysis were made for the following reasons: participants who did not wear the device for at least 4 hours, participants with apnea hypopnea index (AHI) ≥15, and participants with an oxygen desaturation index ≥10.
Statistical methods
SAS software version 9.4, copyright © 2012 SAS Institute Inc, Cary, NC, was used to complete all statistical analyses. Analysis of variance tests for means and χ 2 tests for proportions were used to compare the distributions of the covariates by sleep duration category. Our primary hypothesis testing was conducted using binomial logistic regression analysis; odds ratios and 95% confidence intervals (CIs) are presented. The covariates included in the adjusted model were age, sex, race/ethnicity, education, work status, smoking status, alcohol status, and waist circumference. Preliminary analyses were used to compare numerous strategies to determine the best method to model potential nonlinearity for objective sleep duration. We assessed the crude scatterplots, categorized duration into common sleep categories (b6, 6-7, 7-8, and N8 hours), categorized duration into quartiles, and used a quadratic model. Ultimately, sleep duration was centered at 7.0 hours (the approximate mean for the sample) and the absolute value of the difference from 7.0 was used as a linear exposure. This method provided more stable and interpretable odds ratio estimates.
Individuals missing a PSQI score were excluded from the analyses where PSQI is the primary exposure. The 153 participants with missing PSQI scores were not different from those who did not have a missing PSQI score (data not shown), and no imputation methods were used to predict the scores because scoring protocols indicate that it is not appropriate to do so based on the other completed PSQI questions. 28 For all exposures, a P value less than .05 was considered statistically significant. Effect modification was determined if the χ 2 values corresponding to the multiplicative interaction terms between the main exposure and the covariate of interest (ie, race and sex) were statistically significant at P b .05.
Results
Participants
Of the 599 participants who completed the clinical examination, 50 participants were excluded because they had a high likelihood of sleep apnea based on the ApneaLink screening, 19 participants were excluded because apnea status could not be determined (ie, b4 hours or technical failure), and 20 participants were using medications that would interfere with sleep habits (ie, medications to treat sleep problems, hypnotic antidepressants, sedating antidepressants, or stimulants). This left 510 participants who met the study inclusion criteria. Of these 510, 4 were missing more than 1 exposure variable, 13 were missing a demographic covariate, and 1 was missing a lifestyle behavior covariate. After excluding these participants, 492 individuals remained.
Of the 492 participants included in these analyses, 211 (42.9%) had objective sleep duration between 7 and 8 hours of sleep, 214 (43.5%) had fewer than 7 hours, and 67 (13.6%) had more than 8 hours. The characteristics of the 492 participants are displayed in Table 1 stratified by these commonly used categories of sleep. 33 Participants who slept less than 7 hours were significantly younger, less likely to be female, less likely to be white, and less likely to be retired or unemployed than those who slept 7 or more hours. When sleep duration differs from the recommended amount, waist circumference is higher. There was no statistical difference in BMI. There were no differences by education, lifestyle factors, or depressive symptoms. Sample characteristics presented by race/ethnicity are previously reported. 7 In the overall population, the mean duration of sleep was 7.0 (1.1) hours, the mean fragmentation of sleep was 20.2% (8.0%), the mean score on the Epworth Sleepiness Scale was 6.9 (4.1) points, and the mean score on the PSQI was 5.8 (3.2) points. The numbers of patients with each cardiometabolic risk factor are as follows: 84 (17.1%) had hypertension, 27 (5.5%) had diabetes, and 120 (24.4%) were obese ( Table 2 ). Fig. 1 shows the distribution of the objective and selfreported sleep measures by cardiometabolic risk factor status.
There was no association between objective sleep duration or self-reported daytime sleepiness and odds of hypertension, diabetes, or obesity.
Fragmented sleep was significantly associated with odds of hypertension and obesity. For hypertension, the association was apparent in both unadjusted and adjusted models. The odds ratios in the adjusted model was 1.05 with a 95% CI of 1.01-1.08 (shown in Table 2 ), suggesting that there is approximately a 5% increased odds of hypertension for each additional percentage of fragmented sleep. Fragmented sleep was only significantly associated with odds of obesity in the unadjusted model. The odds ratio was 1.03 with a 95% CI of 1.00-1.05 (shown in Table 2 ), suggesting that there is approximately a 3% increased odds of obesity for each additional percentage of fragmented sleep. Fragmented sleep was not associated with odds of diabetes in either unadjusted or adjusted models.
There was a significant association between self-reported PSQI global sleep quality and odds of hypertension in the unadjusted model (odds ratio, 1.14; 95% CI, 1.05-1.24) that suggested a 14% increased odds of hypertension for each additional point in the PSQI score; however, the statistical significance of this association was attenuated after adjustment for covariates. There was no statistically significant association observed between self-reported PSQI global sleep quality and odds of diabetes or obesity. These results did not change after adjustment for AHI as a continuous variable.
Neither race nor sex was an effect modifier in any association between the sleep characteristics and the cardiometabolic risk factors of interest. There was no evidence of effect modification by race/ethnicity because none of the 3 degree of freedom χ 2 values exceeded 7.815, which would achieve statistical significance at P b .05. Similarly, the multiplicative interaction terms corresponding to the sleep by sex interactions (1 degree of freedom) did not exceed 3.841 and were not significant at P b .05.
Discussion
In our population-based study of adults who had a low likelihood of obstructive sleep apnea, we observed associations of objectively determined sleep fragmentation with hypertension and obesity and an association between perceived PSQI global sleep quality and hypertension. Despite prior research describing an association of short sleep and poor quality sleep with the prevalence of metabolic risk factors, we did not observe such an association using objectively determined sleep measures in our participants who had a low likelihood of having sleep apnea. These patterns were consistent across race/ ethnic groups and among men and women.
Despite observations in other studies, objectively determined sleep duration was not associated with cardiometabolic risk factors in our study. By contrast, the Sleep Heart Health Study observed an odds ratio for hypertension of 1.66 (95% CI, 1.35-2.04) comparing those with fewer than 6 hours of sleep with those with 6 to 9 hours of sleep. Results are reported as n (%) or mean (standard deviation) with the P value for a χ 2 test of proportions (if categorical ⁎ ) or F test from an analysis of variance test (if continuous). U-shaped association in which individuals who sleep above and below 7.5 hours were at a proportionally increased likelihood of obesity. 3 The absence of an association with objective sleep duration in this sample may be because our sample did not include many short sleepers (ie, b6 hours per night) when 7 days of sleep was averaged. Prior studies may have used a shorter observation period for objective measures, thus making it unlikely that they could capture "rebound sleep" that would follow very short sleep periods. Our weeklong measure may have captured this phenomenon and led to a longer "average" for the week. Similarly, short sleep may be a seminal event and when asked to self-report sleep, participants who occasionally or even regularly have nights with very short sleep may recall those nights rather than the weekly average of their sleep. However, it is not known which has a greater influence on cardiometabolic outcomes-very short sleep over a few nights or average sleep over a longer period.
CES-D, Centers for Epidemiologic Studies-Depression.
Sleep fragmentation, an objective assessment of quality, was most strongly associated with the cardiometabolic risk factors in our study. Although we did not find a significant association between sleep fragmentation and diabetes or obesity outside the unadjusted models, there is evidence in the literature to suggest that such an association exits. The Rotterdam study found that the association between sleep duration and obesity was no longer statistically significant after adjustment for sleep fragmentation. 34 Furthermore, they found that for each additional standard deviation of sleep fragmentation, there was a 0.59-kg/m 2 increase in BMI. 34 Their study was conducted in a population of 55 years of age with a low likelihood of sleep apnea (defined by self-report); however, similar methods were used to obtain objective sleep measures via actigraphy. A study of weight loss in women aged 20 to 65 years also found that women with higher levels of sleep fragmentation experienced a lower degree of weight loss. 35 It is possible that the small number of diabetes cases in our study (n = 27) limited our statistical power-particularly after statistical adjustment to capture these associations. We did find an association between sleep fragmentation and hypertension. Our observation is notable because there is evidence that sleep fragmentation is significantly associated with hypertension independent of airway resistance. A study in middle aged nonapneic snorers found that individuals with sleep fragmentation experienced a higher likelihood of hypertension than did those without sleep fragmentation. 36 The authors suggest that the sympathetic nervous system response to sleep fragmentation may have an effect on blood pressure and increase the odds of hypertension. 36 The association in our study between the results of the PSQI and the health outcomes was limited; only the unadjusted model with hypertension was statistically significant. The Cardiovascular Health Epidemiology study similarly found that sleep duration and quality as measured by the PSQI were only moderately associated with obesity. 37 Furthermore, they found that stress was a significant modifier of the interaction and suggested that the 2 must be measured in conjunction. 37 Our study did not take into account perceived stress and this could have limited the comparability of the PSQI scores between participants.
One strength of our study is the use of wrist actigraphy to objectively measure sleep duration and quality, which reduces the measurement error associated with self-reported exposures. Another strength is that we identified and excluded individuals with a high risk of apnea using screening questionnaires and 1 night of home sleep testing. Although some participants with mild symptoms (AHI 5-15) remained in our sample, adjustment for continuous AHI score did not change the adjusted model results. In addition, our participant sample was selected at random, not based on volunteers, and so should not be subject to the bias that could result if adults who were most interested in participating in a study about sleep were those who had sleep-related problems or concerns. Finally, we enrolled approximately equal numbers of whites, blacks, Hispanics, and Asians. Social and cultural factors may also influence perceptions of the amount of sleep that is normal and can influence self-reported sleep. Individuals may misrepresent their actual sleep duration to align themselves with the amount of sleep they perceive to be desirable. 38 Prior studies that include objective assessment of sleep typically only compare 2 race/ethnic groups (eg, white vs black), whereas we also captured information from Asian and Hispanic adults. By using objective measures of sleep, we overcome some of these limitations.
A limitation common to all sleep studies is that the amount of sleep that results in the best health outcomes can vary widely by individual. Although population recommendations reflect the ranges that are commonly associated with the best health outcomes, there are some individuals who require more or less sleep to achieve the best health outcomes. However, this limitation does not affect the calculation of sleep fragmentation, the exposure that was most significantly associated with hypertension and obesity. That fragmentation was significant, and not duration, may be further evidence that the quality of sleep is just as, if not more, important as the amount of sleep. Our conclusions about the association of sleep with obesity are limited to those with class I obesity because the goal of our study was to identify a sample of adults who had a low likelihood of apnea. Given the positive association of obesity with apnea, we did not recruit adults who had a self-reported BMI of 35 kg/m 2 or greater. The use of years of education as a proxy for socioeconomic status is a potential limitation as well. Although education is an indicator likely to capture aspects of lifestyle and behavior, it can have different effects by sex, race, and ethnicity and may not fully capture all aspects of socioeconomic status. 39 This study is cross sectional and, therefore, given the limited ability to determine temporality, there is the potential for bidirectionality of the associations identified.
As the prevalence of obesity, hypertension, and diabetes continues to increase in the population, identifying factors that could contribute to the burden of disease in the population and that can be easily measured is important. Furthermore, our research highlights one health behavior, sleep, that is known to differ by race/ethnicity and that could be the focus of interventions, which could have the significant secondary benefit of reducing disparities in cardiometabolic risk factors. Because there is no single recommended length of sleep time for optimal health given individual biological variability in sleep needs, sleep fragmentation and other measures of sleep quality warrant attention. Additional research should identify the causal pathways and further observe how their effects differ by race, ethnicity, and sex.
